Pandemic Darlings The pandemic economy, in original documents
Home Court filings U.S. v. Aticha Jittaphol Defendant's Memorandum Re Probation Petition -- United States v. Aticha Jittaphol, a/k/…

Court filing

Defendant's Memorandum Re Probation Petition -- United States v. Aticha Jittaphol, a/k/a "Lily"

No. 1:21-cr-10270-MLW · Doc. 48 · Docket on CourtListener

Full text

  Case 1:21-cr-10270-MLW         Document 48      Filed 02/23/22     Page 1 of 10




                      UNITED STATES DISTRICT COURT
                   FOR THE DISTRICT OF MASSACHUSETTS


United States of America                                No. 21-CR-10270-MLW
     v.
Aticha Jittaphol

       DEFENDANT’S MEMORANDUM RE PROBATION PETITION

      The Court should find that Probation has not established “probable cause

to believe that [Ms. Jittaphol] has committed a Federal, State or local crime while

on release,” and has failed to establish probable cause to believe that “there is no

condition or combination of conditions of release that will assure that [Ms.

Jittaphol] will not flee or pose a danger to the safety of any other person or the

community.” See 18 U.S.C. § 3148; United States v. Alfonso, 284 F.Supp.2d 193,

202 (D.Mass 2003). The Court should find that the positive sweat patch result

obtained on February 7th does not establish probable cause to believe that Ms.

Jittaphol used methamphetamine. Inpatient care should not be imposed. No

action should be taken on the petition submitted by Probation on February 7th.

      Methamphetamine usually “can be detected in the urine … anywhere from

3 to 7 days following the last dose.” American Addictions Center, “How Long

Does Meth Stay in Your System,” December 30, 2021,

https://rehabs.com/blog/how-long-does-crytal-meth-stay-in-you-system/.

Christopher C. Cruickshank & Kyle R. Dover, A Review of the Clinical

Pharmacology of Methamphetamine, Addiction 104, 1085-1099 (2009)

(“Amphetamines might be expected to be present in the urine for extended
  Case 1:21-cr-10270-MLW         Document 48       Filed 02/23/22     Page 2 of 10




periods in the context of abuse … methamphetamine has been detected in urine 7

days after completing a regimen of 4 daily 10-mg doses …”).

Sweat patches will test positive based on drug use during any of the time that the

test is worn, typically one week. The positive sweat patch was removed on

January 20th. A negative urine test was conducted the following day. Thus, there

was significant overlap in the dates that these tests covered.

      If Probation now maintains that Ms. Jittaphol should be placed in inpatient

residential care based on a single positive sweat patch test, that position is not

based on the facts, but on a willingness to ignore the facts in favor of a “we told

you so” mentality. This is illustrated by Probation’s readiness to disregard

inherent inconsistencies in its position.

      Probation has asserted that inpatient care is needed because

methamphetamine is extraordinarily addictive. Ms. Jittaphol requested placement

in a detox because she recognized that she could not stop her daily use of

methamphetamine without help. Her subsequent treatment records include candid

discussion of her chronic, daily-use addiction. Methamphetamine is not a drug

that users take occasionally. It provides subjective effects for no more than four

hours, usually prompting addicts to take it several times a day. Daily use or

multiple day binges are routine. See Christopher C. Cruickshank & Kyle R. Dyer,

A Review of the Clinical Pharmacology of Methamphetamine,” Addiction 104,

1085-1099 (2009) (“Acute subjective effects diminish over 4 hours … [which]

may drive repeated use within intervals of 4 hours … a typical pattern of use




                                            2
      Case 1:21-cr-10270-MLW         Document 48       Filed 02/23/22     Page 3 of 10




    appears to consist of four doses daily, in binges lasting 4 days.”). Withdrawal

    symptoms can be severe, including insomnia, depression, anxiety, cognitive

    impairment, agitation, and methamphetamine craving. The absence of

    methamphetamine withdrawal syndrome is associated with a greater likelihood of

    avoiding relapse and is a significant criterion in assessing the need for inpatient

    treatment. See Cruickshank & Dyer, id.; Report of Stuart Gitlow, M.D.,

    previously provided. Ms. Jittaphol’s treatment records do not describe any

    significant withdrawal symptoms.

          Ms. Jittaphol has had at least six urine tests since January, about one per

week. Her first sweat patch was removed on January 14th. It tested negative. It was

replaced by a patch that was removed on January 20th that tested positive. She has

had at least three sweat patches tested since. The results have not been produced.

On February 11th, Probation produced results in its possession; the last being a

urine test from February 3rd. Despite repeated requests, Probation has not

produced any subsequent results. Given that the produced tests show urine results

obtained within a week, and patch results within two weeks, it is likely that

Probation has received results for at least two urine tests since February 3rd and

results for patches removed on January 27th and February 7th or 10th1. Additional

test results likely will be obtained prior to a hearing on this matter. Given that

Probation reported the single positive test immediately, it must be presumed that

all these tests were negative, since no subsequent positive test has been reported.


1
 Ms. Jittaphol’s text messages with Ms. Wertz leave it unclear whether she went to court
for testing on February 7th or 10th.


                                              3
  Case 1:21-cr-10270-MLW          Document 48        Filed 02/23/22    Page 4 of 10




        An updated list of the tests since January is provided:

Type of Test          Date of Sample       Date of Result         Result

Urine                 1/11/22              1/18/22                Negative

Patch                 1/14/22              1/27/22                Negative

Patch                 1/20/22              2/7/22                 Positive

Urine                 1/21/22              1/27/22                Negative

Urine                 1/26/22              2/1/22                 Negative

Patch                 1/27/22              not produced           Presumed Negative

Urine                 2/3/22               2/7/22                 Negative

Urine                 2/7/22 or            not produced           Presumed Negative
                      2/10/22

Patch                 2/7/22 or            not produced           Presumed Negative
                      2/10/22

Urine                 2/17/22              not produced           Presumed Negative

Patch                 2/17/22              not produced           Pending

        There is an obvious inconsistency in asserting that methamphetamine is so

addictive that Ms. Jittaphol needs inpatient care to avoid using but has managed

to use only sporadically since her release from The Hope Center, perhaps only

during the week prior to the positive sweat patch test, and perhaps only during

the early days of that week, which may not have been covered by urinalysis.

        Ms. Jittaphol’s most recent urine test was February 17th. Once again, she

asked to be observed. Given Probation’s February 14th memorandum, stating a

willingness to perform observed urine screens so long as a male probation officer




                                           4
 Case 1:21-cr-10270-MLW          Document 48      Filed 02/23/22     Page 5 of 10




was available, she had reason to believe that the sampling would be observed.

Instead, she again was told it was not necessary. Probation has not conducted any

observed tests. To the extent that Probation asserts that the urine tests are

unreliable, Probation has created and maintained this excuse by failing to conduct

supervised sampling despite Ms. Jittaphol’s repeated requests.

      Any assertion that Ms. Jittaphol could manage to provide someone else’s

urine and get away with it every week this year is nonsensical. There is nothing

about Ms. Jittaphol to even remotely suggest that she could succeed at such

deception, or that she’d want to. Is someone looking at her before she goes into

the restroom to see if there’s a hidden bottle of urine? Or is Probation so inept, or

Ms. Jittaphol so sleightful, that week in and week out she’s able to hide the bottles

without getting caught? If she was bringing someone else’s urine into the

courthouse again and again, why would she repeatedly ask Probation to have

someone observe her urinate? If she’s using methamphetamine, this

extraordinarily addictive drug that routinely involves daily use, how do you

explain all the negative tests, including sweat patch tests? Rather than struggle to

come up with answers to these obvious questions, there is another obvious

explanation – the sole positive sweat patch test was wrong.

      In Alfonso, 284 F.Supp.2d at 193, Judge Young discussed some of the

literature warning of the risk of false positives from sweat patch tests, and

literature documenting reliability problems with sweat patch testing has mounted

since. See Marilyn A Huestis, et al., Monitoring Opiate Use in Substance Abuse




                                         5
 Case 1:21-cr-10270-MLW         Document 48      Filed 02/23/22    Page 6 of 10




Treatment Patients with Sweat and Urine Drug Testing, J Analytical Toxicology

24, 509-521 (2000) (“… 7.9% false-positive sweat results as compared to urine

tests.”); David A. Kidwell & Frederick P. Smith, Susceptibility of PharmChek

Drugs of Abuse Patch to Environmental Contamination, Forensic Science Intl

116, 89-106 (2001) (“ … normal hygiene did not remove all drugs from

externally contaminated skin [of drug-free subjects] and positive sweat patches

resulted.”); Joseph A. Levisky, et al., Comparison of Urine to Sweat Patch Test

Results in Court Ordered Testing, Forensic Science International 122, 65-68

(2001) (a “… high incidence of false positive sweat patch tests,” referencing

studies reporting false positive rates of 21.1% in cocaine detection and 7.9% in

opiate detection.); Melissa Long & David A. Kidwell, Improving the Pharmcheck

Sweat Patch: Reducing False Positives from Environmental Contamination and

Increasing Drug Detection, Dept of Justice Final Report (2002) (“Urine tests on

individuals have shown urine negative/patch positive results with close contact

with a drug-contaminated environment. Several cases have involved individuals

identified as methamphetamine positive who denied any methamphetamine use,

while admittedly using other drugs. The individuals involved in these cases were

all in environments where profuse sweating was common …”); D. A. Kidwell, et

al., Comparison of Daily Urine, Sweat, and Skin Swabs Among Cocaine Users,

Forensic Sci Int 133 (1-2), 63-78 (2003) (“… patch results may represent current

use, prior use, contamination, or a combination … false positives occurred at a

7% rate.”); Marek C. Chawarski, et al., Utility of Sweat Patch Testing for Drug




                                        6
  Case 1:21-cr-10270-MLW        Document 48       Filed 02/23/22    Page 7 of 10




Use Monitoring in Outpatient Treatment for Opiate Dependence, J Subst Abuse

Treat 33(4), 411-415 (2007) (“… sweat testing is less sensitive than weekly urine

testing in detecting opiate use;” “… precautionary measures, including cleansing

the skin before patch application are not completely reliable in preventing

contamination …”); N. De Giovanni & N. Fucci, The Current Status of Sweat

Testing for Drugs of Abuse: A Review, Current Medicinal Chemistry 20, 545-

5671 (2013) (“For chronic users it is not clear whether a cocaine appearing in the

patches came from current drug ingestion, previous drug ingestion, previous drug

contamination, current drug contamination, or a combination of the above … The

effects of vigorous or prolonged exercise on the transfer of drugs into sweat

and/or the disposition of these drugs onto the patch are unknown and there is

evidence that outward transdermal migration of some accumulated drugs may

lead to an incorrect interpretation of new drug use.”); Joy N. Hussain, et al.,

Working Up a Good Sweat – The Challenges of Standardizing Sweat Collection

for Metabolomics Analysis, Clin Biochem Rev 38, 13-38 (2017) (Sweat from

exercise may have a different metabolic content, and may impact test results).

      Ms. Jittaphol sometimes strenuously exercises. The Fucci, Long, Huestis

and Hussain articles referenced above each describe or suggest a risk of higher

rates of false positive sweat patch results amongst past drug users where there is

an increase in sweating caused by vigorous exercise.

      In Alfonso, there were six positive sweat patch tests. Judge Young dismissed

two as unreliable based on the way the patches were removed. He emphasized the




                                         7
  Case 1:21-cr-10270-MLW          Document 48        Filed 02/23/22     Page 8 of 10




significance of the remaining four positive tests: “[t]he Court deems it important to

note that it was the aggregate of positive results that provided probable cause to

believe that Alfonso used cocaine while on supervised release.” Alfonso, 284

F.Supp.2d at 204. In this case, not only is there only one positive test, but that test

is inconsistent with all the other tests, including a negative urine test that

overlapped part of the time when the positive sweat patch was worn, and involves

a drug that is less likely to be used sporadically than cocaine.

       Probation has never addressed the assertion that a recommendation for

long-term inpatient was improper from the start and a deviation from the standard

of care. Probation has never disputed that The Hope Center failed to assess

whether such care was warranted. Never disputed that the clinical supervisor in

charge of Ms. Jittaphol’s care at The Hope Center, Hilary Moody, stated that The

Hope Center did not assess whether inpatient residential care was appropriate

because it understood that the treatment plan had been dictated by Probation’s

P45 form, which was interpreted as a “contract” requiring long-term residential

care. Never disputed that Ms. Moody acknowledged that Ms. Jittaphol did not

meet the criteria applied to determine whether inpatient care is warranted. Never

disputed that Probation’s recommendation for inpatient treatment was based on

the recommendation of The Hope Center, not on any independent assessment,

because Probation is not qualified to make such an assessment, and that The Hope

Center’s recommendation, in turn, was based on a misinterpretation of the P45

form, not on a clinical assessment. Never disputed any of the facts or opinions




                                            8
  Case 1:21-cr-10270-MLW          Document 48       Filed 02/23/22    Page 9 of 10




stated by Dr. Stuart Gitlow in his letter concluding that the recommendation for

inpatient residential care was a breach of the standard of care, lacked support in

clinical findings, and was unsupported by treatment record documentation of any

of the criteria deemed essential to warrant inpatient residential care.

       Even if the one positive sweat patch test was legitimate, that alone would

not justify inpatient care, given all the other negative tests. There has never been a

clinical assessment of the need for inpatient treatment, and there should be no

consideration of inpatient treatment unless a qualified care provider finds it

appropriate. At that point, Ms. Jittaphol should have an opportunity to challenge

such a finding. However, a single positive sweat patch test does not establish

probable cause to believe that Ms. Jittaphol used methamphetamine. There is

ample reason to find it likely that the positive test was false. No action should be

taken on Probation’s petition and Ms. Jittaphol should not be required to

participate in inpatient treatment. She does not object to outpatient counselling

and has worked with Probation to arrange it. The Court should accept the parties’

“C Plea,” and to the extent that a qualified clinician believes that outpatient

counselling is warranted for Ms. Jittaphol to maintain sobriety, this would be an

appropriate condition of Probation.

                                                   ATICHA JITTAPHOL
                                                   By her Attorney,

                                                   /s/ Keith Halpern
                                                   Keith Halpern, BBO # 545282
                                                   572 Washington Street, Suite 19
                                                   Wellesley, MA 02482
                                                   (617) 722-9952


                                           9
 Case 1:21-cr-10270-MLW              Document 48         Filed 02/23/22        Page 10 of 10




                                   CERTIFICATE OF SERVICE
        I hereby certify that this document, filed through the ECF system, will be sent
electronically to the registered participants as identified on the Notice of Electronic Filing
(NEF) and paper copies will be sent to those indicated as non-registered participants on
February 23, 2022.
                                                          /s/ Keith Halpern




                                               10


File and source

File
gov.uscourts.mad.237964.48.0.pdf
Size
207,454 bytes
SHA-256
f638a61cfe2eba1691e51ec1bddc6df8836f0b01e149fbbac639fd77774aff29
Our copy
gov.uscourts.mad.237964.48.0.pdf
Original
PACER (login required)
Back to top